Table 5 SGA adjusted odds ratio for gestational exposure to internal dose THMs
THM exposure Tertile limits (mg/d) | SGA cases | Non SGA | Entire pregnancy ORa95% CI | First trimester ORa95% CI | Second trimester ORa95% CI | Third trimester ORa95% CI |
|---|---|---|---|---|---|---|
TTHMb | Â | Â | Â | Â | Â | Â |
0.0025-0.0386 | 76 | 1010 | Reference | Reference | Reference | Reference |
0.0386-0.3545 | 92 | 1058 | 1.18 (0.86-1.82) | 1.13 (0.82-1.54) | 1.18 (0.86-1.62) | 1.17 (0.85-1.60) |
0.3545-2.4040 | 102 | 1003 | 1.34 (0.98-1.84) | 1.27 (0.93-1.73) | 1.33 (0.97-1.82) | 1.22 (0.89-1.67) |
Continuous 0.1 μg/L |  |  | 1.03 (0.99-1.07) | 1.02 (0.98-1.06) | 1.03 (0.99-1.07) | 1.02 (0.98-1.06) |
Chloroform | Â | Â | Â | Â | Â | Â |
0.0013-0.0249 | 78 | 1012 | Reference | Reference | Reference | Reference |
0.0249-0.2868 | 91 | 1054 | 1.16 (0.84-1.59) | 1.19 (0.86-1.63) | 1.12 (0.82-1.54) | 1.19 (0.87-1.63) |
0.2868-2.1328 | 101 | 1005 | 1.31 (0.96-1.79) | 1.30 (0.95-1.77) | 1.28 (0.94-1.74) | 1.22 (0.89-1.68) |
Continuous 0.1 μg/L |  |  | 1.03 (0.99-1.08) | 1.03 (0.99-1.08) | 1.03 (0.99-1.08) | 1.04 (1.00-1.09) |
CHBrCl2 | Â | Â | Â | Â | Â | Â |
0.0001-0.0124 | 73 | 1018 | Reference | Reference | Reference | Reference |
0.0124-0.0501 | 101 | 1045 | 1.35 (0.99-1.86) | 1.21 (0.88-1.67) | 1.20 (0.88-1.65) | 1.37 (1.00-1.88) |
0.0501-0.3359 | 96 | 1008 | 1.29 (0.94-1.78) | 1.35 (0.99-1.85) | 1.23 (0.90-1.69) | 1.25 (0.91-1.73) |
Continuous 0.01 μg/L |  |  | 1.21 (0.90-1.62) | 1.19 (0.87-1.62) | 1.19 (0.89-1.60) | 1.20 (0.90-1.62) |
CHBr2Cl | Â | Â | Â | Â | Â | Â |
0.0000-0.0000 | 102 | 1013 | Reference | Reference | Reference | Reference |
0.0000-0.0039 | 78 | 1045 | 0.77 (0.56-1.05) | 0.76 (0.54-1.07) | 0.66 (0.48-0.91) | 1.76 (0.56-1.03) |
0.0039-0.0644 | 90 | 1012 | 0.89 (0.66-1.21) | 0.88 (0.67-1.17) | 0.90 (0.68-1.21) | 0.85 (0.63-1.15) |
Continuous 0.01 μg/L |  |  | 1.05 (0.89-1.24) | 1.05 (0.86-1.26) | 1.05 (0.86-1.26) | 1.06 (0.92-1.22) |